Establishment and characterization of 12 human colorectal-carcinoma cell lines

International Journal of Cancer

Volumn 81, Issue 6, 1999, Pages 902-910

  Oh, Jae Hwan ^a   Ku, Ja Lok ^a   Yoon, Kyong Ah ^a   Kwon, Hyuk Joon ^a   Kim, Woo Ho ^a   Park, Hyun Sook ^a   Yeo, Kyong Sook ^a   Song, Sang Yong ^a   Chung, June Key ^a   Park, Jae Gahb ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADENOCARCINOMA; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; COLORECTAL CANCER; CONTROLLED STUDY; DNA FINGERPRINTING; GENE DELETION; HUMAN; HUMAN CELL; METASTASIS; METHYLATION; MUCINOUS CARCINOMA; MUTATION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADULT; AGED; BETA CATENIN; CARRIER PROTEINS; CELL CULTURE TECHNIQUES; CELL CYCLE PROTEINS; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYTOSKELETAL PROTEINS; DNA REPAIR; FEMALE; GENES, APC; GENES, P16; GENES, P53; GENES, RAS; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MUTATION; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROTEINS; RECTAL NEOPLASMS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0032969751     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990611)81:6<902::AID-IJC11>3.0.CO;2-T     Document Type: Article

References (32)

1. AALTONEN, L.A. and 14 OTHERS, Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Res., 54, 1645-1648 (1994).
2. BAKER, S.J., PREISINGER, A.C., JESSUP, J.M., PARASKEVA, C., MARKOWITZ, S., WILLSON, J.K.V., HAMILTON, S. and VOGELSTEIN, B., p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res., 50, 7717-7722 (1990).
3. BARBACID, M., ras genes. Ann. Rev. Biochem., 56, 779-827 (1987).
4. BORDES, M., MICHELS, R. and MARTIN, F., Detection by immunofluorescence of carcinoembryonic antigen in colonic carcinoma, other malignant or benign tumours, and non-cancerous tissues. Digestion, 9, 106-115 (1973).
5. BOS, J.L., ras oncogenes in human cancer: a reviews. Cancer Res., 49, 4682-4689 (1989).
6. BROWER, M., CARNEY, D.N., OIE, H.K., GAZDAR, A.F. and MINNA, J.D., Growth of cell lines and clinical specimens of human non-small-cell lung cancer in a serum-free defined medium. Cancer Res., 46, 798-806 (1986).
7. CHO, Y., GORINA, S., JEFFREY, P. and PAVLETICH, N.P., Crystal structure of a p53-tumor-suppressor-DNA complex: understanding tumorigenic mutations. Science, 265, 346-355 (1994).
8. FISHEL, R., LESCOE, M.K., RAO, M.R.S., COPELAND, N.G., JENKINS, N.A., GARNER, J., KANE, M. and KOLODNER, R., The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell, 75, 1027-1038 (1993).
9. GONZALEZ-ZULUETA, M., BENDER, C.M. and JONES, P.A., Methylation of the 5′ CpG island of the p16/cdkn2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res., 55, 4531-4535 (1995).
10. GREENBLATT, M.S., BENNETT, W.P., HOLLSTEIN, M. and HARRIS, C.C., Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54, 4855-4878 (1994).
11. HAN, H.J., YANAGISAWA, A., KATO, Y., PARK, J.-G. and NAKAMURA, Y., Genetic instability in pancreatic cancer and poorly differentiated type of gastric cancer. Cancer Res., 53, 5087-5089 (1993).
12. HAN, H.J. and 14 OTHERS, Germline mutations of hMLH1 and hMSH2 genes in Korean hereditary nonpolyposis colorectal cancer. J. nat. Cancer. Inst., 88, 1317-1319 (1996).
13. HERMAN, J.G., MERLO, A., MAO, L., LAPIDUS, R.G., ISSA, J.-P.J., DAVIDSON, N.E., SIDRANSKY, D. and BAYLIN, S.B., Inactivation of the CDKN2/p16/ MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res., 55, 4525-4530 (1995).
14. HOLLSTEIN, M., SIDRANSKY, D., VOGELSTEIN, B. and HARRIS, C.C., p53 mutations in human cancer. Science, 253, 49-53 (1991).
15. HUANG, J. and 12 OTHERS, APC mutations in colorectal tumors with mismatch repair deficiency. Proc. nat. Acad. Sci. (Wash.), 93, 9049-9054 (1996).
16. IWAO, K., NAKAMORI, S., KAMEYAMA, M., IMAOKA, S., KINOSHITA, M., FUKUI, T., ISHIGURO, S., NAKAMURA, Y. and MIYOSHI, Y., Activation of the β-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations. Cancer Res., 58, 1021-1026 (1998).
17. KAMB, A., GRUIS, N.A., WEAVER-FELDHAUS, J., LIU, Q., HARSHMAN, K., TAVTIGIAN, S.V., STOCKERT, E., DAY, R.S. III, JOHNSON, B.E. and SKOLNICK, M.H., A cell cycle regulator potentially involved in genesis of many tumor types. Science, 264, 436-440 (1994).
18. KANG, M.S., LEE, H.J., KU, J.L., LEE, K.P., KELLY, M.J., WON, Y.J., KIM, S.T. and PARK, J.G., Mutation of p53 gene in hepatocellular-carcinoma cell lines with HBX DNA. Int. J. Cancer, 67, 898-902 (1996).
19. KITAEVA, M.N., GROGAN, L., WILLIAMS, J.P., DIMOND, E., NAKAHARA, K., HAUSNER, P., DENOBILE, J.W., SOBALLE, P.W. and KIRSCH, I.R., Mutations in β-catenin are uncommon in colorectal cancer occurring in occasional replication error-positive tumors. Cancer Res., 57, 4478-4481 (1997).
20. MIYOSHI, Y. and 13 OTHERS, Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients. Proc. nat. Acad. Sci. (Wash.), 89, 4452-4456 (1992).
21. ORLOW, I., LACOMBE, L., HANNON, G.J., SERRANO, M., PELLICER, I., DALBAGNI, G., REUTER, V.E., ZHANG, Z.F., BEACH, D. and CORDON-CARDO, C., Deletion of the p16 and p15 genes in human bladder tumors. J. nat. Cancer Inst., 87, 1524-1529 (1995).
22. PALACIOS, J. and GAMALLO, C., Mutations in the β-catenin gene (CTNNB1) in endometrioid ovarian carcinomas. Cancer Res., 58, 1344-1347 (1998).
23. PAPADOPOULOS N. and 19 OTHERS, Mutation of a mutL homolog in hereditary colon cancer. Science, 263, 1625-1629 (1994).
24. PARK, J.-G. and 17 OTHERS, Characterization of cell lines established from human hepatocellular carcinoma. Int. J. Cancer, 62, 276-282 (1995).
25. PARK, J.-G., OIE, H.K., SUGARBAKER, P.H., HENSLEE, J.G., CHEN, T.-R., JOHNSON, B.E. and GAZDAR, A.F., Characteristics of cell lines established from human colorectal carcinoma. Cancer Res., 47, 6710-6718 (1987).
26. PARK, J.-G., YANG, H.-K. and HAY, R.J., Colorectal cancer cell lines. In: R.J. Hay, J.-G. Park and A. Gazdar (eds.), Atlas of human tumor cell lines. pp. 317-341 Academic Press, San Diego (1994).
27. PARKER, S., TONG, T., BOLDEN, S. and WINGO, P., Cancer statistics. CA Cancer J. Clin., 46, 5-27 (1996).
28. SHI, Z.R., TSAO, D. and KIM, Y.S., Subcellular distribution, synthesis and release of carcinoembryonic antigen in cultured human colon adenocarcinoma cell lines. Cancer Res., 43, 4045-4049 (1983).
29. SMITH, K.J., JOHNSON, K.A., BRYAN, T.M., HILL, D.E., MARKOWITZ, S., WILLSON, J.K.V., PARASKEVA, C., PETERSEN, G.M., HAMILTON, S.R., VOGELSTEIN, B. and KINZLER, K.W., The APC gene product in normal and tumor cells. Proc. nat. Acad. Sci. (Wash.), 90, 2846-2850 (1993).
30. SOUSSI, T., CARON DE FROMENTEL, C. and MAY, P., Structural aspects of the p53 protein in relation to gene evolution. Oncogene, 5, 945-952 (1990).
31. VOGELSTEIN, B., FEARON, E.R., HAMILTON, S.R., KERN, S.E., PREISINGER, A.C., LEPPERT, M., NAKAMURA, Y., WHITE, R., SMITS, A.M. and BOS, J.L., Genetic alterations during colorectal-tumor development. New Engl. J. Med., 319, 525-532 (1988).
32. WILLIAMSON, M.P., ELDER, P.A., SHAW, M.E., DEVLIN, J. and KNOWLES, M.A., p16(CDKN2) is a major deletion target at 9p21 in bladder cancer. Hum. mol. Genet., 4, 1569-1577 (1995).